Plectasin, first animal Toxin-Like fungal defensin blocking potassium channels through recognizing channel pore region

Toxins

Volumn 7, Issue 1, 2015, Pages 34-42

  Xiang, Fang ^a   Xie, Zili ^a   Feng, Jing ^a   Yang, Weishan ^a   Cao, Zhijian ^a   Li, Wenxin ^a   Chen, Zongyun ^a   Wu, Yingliang ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Defensin; Functional evolution; Kv1.3 channel; Molecular mechanism; Plectasin; Potassium channels

Indexed keywords

CHARYBDOTOXIN; PLECTASIN; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNQ; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.2; SCORPION VENOM; DEFENSIN; MYCOTOXIN; PEPTIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CHANNEL GATING; CONTROLLED STUDY; DISULFIDE BOND; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; MUTAGENESIS; PATCH CLAMP TECHNIQUE; POTASSIUM CURRENT; PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; HEK293 CELL LINE; PHYSIOLOGY;

ANIMALIA; FUNGI; SCORPIONES;

DEFENSINS; HEK293 CELLS; HUMANS; MYCOTOXINS; PEPTIDES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS;

EID: 84921743972     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins7010034     Document Type: Article

References (27)

1. Shieh, C.C.; Coghlan, M.; Sullivan, J.P.; Gopalakrishnan, M. Potassium channels: Molecular defects, diseases, and therapeutic opportunities. Pharmacol. Rev. 2000, 52, 557-594.
2. Mouhat, S.; Andreotti, N.; Jouirou, B.; Sabatier, J.M. Animal toxins acting on voltage-gated potassium channels. Curr. Pharm. Des. 2008, 14, 2503-2518.
3. Feng, J.; Hu, Y.; Yi, H.; Yin, S.; Han, S.; Hu, J.; Chen, Z.; Yang, W.; Cao, Z.; de Waard, M.; et al. Two conserved arginine residues from the SK3 potassium channel outer vestibule control selectivity of recognition by scorpion toxins. J. Biol. Chem. 2013, 288, 12544-12553.
4. − effector memory T cell activation by a novel peptide targeting Kv1.3 channel in a rat experimental autoimmune encephalomyelitis model. J. Biol. Chem. 2012, 287, 29479-29494.
5. Beeton, C.; Wulff, H.; Standifer, N.E.; Azam, P.; Mullen, K.M.; Pennington, M.W.; Kolski-Andreaco, A.; Wei, E.; Grino, A.; Counts, D.R.; et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc. Natl. Acad. Sci. USA 2006, 103, 17414-17419.
6. Rashid, M.H.; Kuyucak, S. Free energy simulations of binding of HsTx1 toxin to Kv1 potassium channels: The basis of Kv1.3/Kv1.1 selectivity. J. Phys. Chem. B 2014, 118, 707-716.
7. Jin, L.; Wu, Y. Molecular mechanism of the sea anemone toxin ShK recognizing the Kv1.3 channel explored by docking and molecular dynamic simulations. J. Chem. Inf. Model. 2007, 47, 1967-1972.
8. Chen, R.; Robinson, A.; Gordon, D.; Chung, S.H. Modeling the binding of three toxins to the voltage-gated potassium channel (Kv1.3). Biophys. J. 2011, 101, 2652-2660.
9. Rashid, M.H.; Kuyucak, S. Affinity and selectivity of ShK toxin for the Kv1 potassium channels from free energy simulations. J. Phys. Chem. B 2012, 116, 4812-4822.
10. Spelbrink, R.G.; Dilmac, N.; Allen, A.; Smith, T.J.; Shah, D.M.; Hockerman, G.H. Differential antifungal and calcium channel-blocking activity among structurally related plant defensins. Plant Physiol. 2004, 135, 2055-2067.
11. Ng, T.B.; Cheung, R.C.; Wong, J.H.; Ye, X.J. Antimicrobial activity of defensins and defensin-like peptides with special emphasis on those from fungi and invertebrate animals. Curr. Protein Pept. Sci. 2013, 14, 515-531.
12. Yi, H.Y.; Chowdhury, M.; Huang, Y.D.; Yu, X.Q. Insect antimicrobial peptides and their applications. Appl. Microbiol. Biotechnol. 2014, 98, 5807-5822.
13. Tassanakajon, A.; Somboonwiwat, K.; Amparyup, P. Sequence diversity and evolution of antimicrobial peptides in invertebrates. Dev. Comp. Immunol. 2015, 48, 324-341.
14. Yang, W.; Feng, J.; Xiang, F.; Xie, Z.; Zhang, G.; Sabatier, J.M.; Cao, Z.; Li, W.; Chen, Z.; Wu, Y. Endogenous animal toxin-like human beta-defensin 2 inhibits own K channels through interaction with channel extracellular pore region. Cell. Mol. Life Sci. 2014, doi:10.1007/s00018-014-1715-z.
15. Mygind, P.H.; Fischer, R.L.; Schnorr, K.M.; Hansen, M.T.; Sonksen, C.P.; Ludvigsen, S.; Raventos, D.; Buskov, S.; Christensen, B.; de Maria, L.; et al. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 2005, 437, 975-980.
16. Brinch, K.S.; Sandberg, A.; Baudoux, P.; van Bambeke, F.; Tulkens, P.M.; Frimodt-Moller, N.; Hoiby, N.; Kristensen, H.H. Plectasin shows intracellular activity against Staphylococcus aureus in human THP-1 monocytes and in a mouse peritonitis model. Antimicrob. Agents Chemother. 2009, 53, 4801-4808.
17. Schneider, T.; Kruse, T.; Wimmer, R.; Wiedemann, I.; Sass, V.; Pag, U.; Jansen, A.; Nielsen, A.K.; Mygind, P.H.; Raventos, D.S.; et al. Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 2010, 328, 1168-1172.
18. Gan, G.; Yi, H.; Chen, M.; Sun, L.; Li, W.; Wu, Y.; Ding, J. Structural basis for toxin resistance of beta4-associated calcium-activated potassium (BK) channels. J. Biol. Chem. 2008, 283, 24177-24184.
19. Qiu, S.; Yi, H.; Liu, H.; Cao, Z.; Wu, Y.; Li, W. Molecular Information of charybdotoxin blockade in the large conductance calcium-activated potassium channel. J. Chem. Inf. Model. 2009, 49, 1831-1838.
20. + channel. Elife 2013, 2, e00594.
21. Han, S.; Yi, H.; Yin, S.J.; Chen, Z.Y.; Liu, H.; Cao, Z.J.; Wu, Y.L.; Li, W.X. Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease. J. Biol. Chem. 2008, 283, 19058-19065.
22. Yin, S.J.; Jiang, L.; Yi, H.; Han, S.; Yang, D.W.; Liu, M.L.; Liu, H.; Cao, Z.J.; Wu, Y.L.; Li, W.X. Different residues in channel turret determining the selectivity of ADWX-1 inhibitor peptide between Kv1.1 and Kv1.3 channels. J. Proteome Res. 2008, 7, 4890-4897.
23. Chen, Z.; Hu, Y.; Hu, J.; Yang, W.; Sabatier, J.M.; de Waard, M.; Cao, Z.; Li, W.; Han, S.; Wu, Y. Unusual binding mode of scorpion toxin BmKTX onto potassium channels relies on its distribution of acidic residues. Biochem. Biophys. Res. Commun. 2014, 447, 70-76.
24. Chen, Z.Y.; Hu, Y.T.; Yang, W.S.; He, Y.W.; Feng, J.; Wang, B.; Zhao, R.M.; Ding, J.P.; Cao, Z.J.; Li, W.X.; et al. Hg1, novel peptide inhibitor specific for Kv1.3 channels from first scorpion Kunitz-type potassium channel toxin family. J. Biol. Chem. 2012, 287, 13813-13821.
25. Chi, V.; Pennington, M.W.; Norton, R.S.; Tarcha, E.J.; Londono, L.M.; Sims-Fahey, B.; Upadhyay, S.K.; Lakey, J.T.; Iadonato, S.; Wulff, H.; et al. Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases. Toxicon 2012, 59, 529-546.
26. Chen, R.; Chung, S.H. Engineering a potent and specific blocker of voltage-gated potassium channel Kv1.3, a target for autoimmune diseases. Biochemistry 2012, 51, 1976-1982.
27. Hou, P.; Zhang, R.; Liu, Y.; Feng, J.; Wang, W.; Wu, Y.; Ding, J. Physiological role of Kv1.3 channel in T lymphocyte cell investigated quantitatively by kinetic modeling. PLoS One 2014, 9, e89975.